ScholarIQanswers from OpenAlex & ORCID
Michael J. Eck
ResearcherPublications, citations & collaboration network
Michael J. Eck is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael J. Eck have?
ScholarIQindexed works
Michael J. Eck has 421 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael J. Eck have?
ScholarIQcitation count
Michael J. Eck has 47,900 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael J. Eck?
ScholarIQh-index
Michael J. Eck has an h-index of 91 in OpenAlex.
What is the i10-index of Michael J. Eck?
ScholarIQi10-index
Michael J. Eck has an i10-index of 161 in OpenAlex.
What is the ORCID of Michael J. Eck?
ScholarIQorcid
The ORCID for Michael J. Eck is on the source record.
What is the OpenAlex record for Michael J. Eck?
ScholarIQopenalex
The OpenAlex for Michael J. Eck is on the source record.
What are the most-cited papers on Michael J. Eck?
ScholarIQmost cited works
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J. Kaye, Neal I. Lindeman, Titus J. Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J. Eck, William R. Sellers, Bruce E. Johnson, Matthew Meyerson
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
Hiroyuki Yasuda, Eunyoung Park, Cai-Hong Yun, Natasha Sng, Antonio R. Lucena‐Araujo, Wee-Lee Yeo, Mark S. Huberman, David Cohen, Sohei Nakayama, Kota Ishioka, Norihiro Yamaguchi, Megan Hanna, Geoffrey R. Oxnard, Christopher S. Lathan, Teresa Morán, Lecia V. Sequist, Jamie E. Chaft, Gregory J. Riely, Maria E. Arcila, Ross A. Soo, Matthew Meyerson, Michael J. Eck, Susumu Kobayashi, Daniel B. Costa
Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Peter S. Hammerman, Martin L. Sos, Alex H. Ramos, Chunxiao Xu, Amit Dutt, Wenjun Zhou, Lear E. Brace, Brittany A. Woods, Wenchu Lin, Jianming Zhang, Xianming Deng, Sang Min Lim, Stefanie Heynck, Martin Peifer, Jeffrey R. Simard, Michael S. Lawrence, Robert C. Onofrio, Helga B. Salvesen, Danila Seidel, Thomas Zander, Johannes M. Heuckmann, Alex Soltermann, Holger Moch, Mirjam Koker, Frauke Leenders, Franziska Gabler, Silvia Querings, Sascha Ansén, Élisabeth Brambilla, Christian Brambilla, Philippe Lorimier, Odd Terje Brustugun, Åslaug Helland, Iver Petersen, Joachim H. Clement, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erich Stoelben, Jürgen Wolf, David G. Beer, Ming‐Sound Tsao, Megan Hanna, Charlie Hatton, Michael J. Eck, Pasi A. Jänne, Bruce E. Johnson, Wendy Winckler, Heidi Greulich, Adam J. Bass, Jeonghee Cho, Daniel Rauh, Nathanael S. Gray, Kwok‐Kin Wong, Eric B. Haura, Roman K. Thomas, Matthew Meyerson
The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers
Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng, James E. Butrynski, Marzia Capelletti, Liping Wang, Nathanael S. Gray, Keith D. Wilner, James G. Christensen, George D. Demetri, Geoffrey I. Shapiro, Scott J. Rodig, Michael J. Eck, Pasi A. Jänne